Psoriasis is an immune-mediated, inflammatory disease, and it is well known that the tumor necrosis factor (TNF)-α inhibitors are associated with enhanced risk of reactivation of latent tuberculosis infection. The gene discussed is TNF; the disease is psoriasis.